Residual disability, estimated to affect 6% of neurologic patients, is the most feared outcome of cobalamin deficiency and is likely to persist if still present after 6 to 12 months of treatment
(3) N Vasireddi, H Hahamyan, M J Salata, et al (2025) Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review HSS Journal, 2025 Jul 31, 15563316251355551
If youre dealing with these symptoms, B12 shots could be just what you need to feel better
BPC-157 Extensive animal and in-vitro studies on tendon, ligament, and gut tissue
Evaluating the Evidence Conclusion Understanding Autoimmune Conditions Autoimmune diseases arise when the immune system mistakenly attacks healthy cells instead of invaders